Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is shown on the page, and Revision: v3.3.1 has been removed.
    Difference
    0.1%
    Check dated 2025-12-01T17:48:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added replacing v3.2.0, a minor site version update with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:44:44.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The government funding operating-status notice at the top was removed. Study details and navigation remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T07:15:09.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Administrative updates were made to the study record, including last update dates and QC criteria; no changes to the study design, eligibility criteria, primary or secondary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:49.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    3%
    Check dated 2025-10-05T10:09:48.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Update to v3.1.0 with removal of the Acute lymphoblastic leukemia resource and addition of a new Revision tag.
    Difference
    0.4%
    Check dated 2025-09-28T03:13:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.